Curia Unveils Comprehensive mRNA Solution
Curia, formerly AMRI, a leading contract research, development and manufacturing organization, today unveiled its messenger RNA (mRNA) solution, which includes discovery, process development and mRNA drug substance production, through large-scale lipid manufacturing, lipid nanoparticle (LNP) formulation and development for full-scale sterile fill-finish services.
United States John Ratliff Debra Harrsch Development Of Lipid Nanoparticle Formulation Development Of Lipid Media Communications
Source: businesswireindia.com